DropWise: current role and future perspectives of dried blood spots (DBS), blood microsampling, and their analysis in sports drug testing

Publication: Contribution to journalJournal articlesResearchpeer-review

Abstract

For decades, blood testing has been an integral part of routine doping controls. The breadth of information contained in blood samples has become considerably more accessible for anti-doping purposes over the last 10?years through technological advancements regarding analytical instrumentation as well as enhanced sample collection systems. Particularly, microsampling of whole blood and serum, for instance as dried blood spots (DBS), has opened new avenues in sports drug testing and substantially increased the availability and cost-effectiveness of doping control specimens. Thus, microvolume blood specimens possess the potential to improve monitoring of blood hormone and drug levels, support evaluation of circulating drug concentrations in competition, and enhance the stability of labile markers and target analytes in blood passport analyses as well as peptide hormone and steroid ester detection. Further, the availability of the fraction of lysed erythrocytes for anti-doping purposes warrants additional investigation, considering the sequestering capability of red blood cells (RBCs) for certain substances, as a complementary approach in support of the clean sport.
Original languageEnglish
JournalCritical Reviews in Clinical Laboratory Sciences
Pages (from-to)1-22
Number of pages22
DOIs
Publication statusPublished - 07.08.2022

Fingerprint

Dive into the research topics of 'DropWise: current role and future perspectives of dried blood spots (DBS), blood microsampling, and their analysis in sports drug testing'. Together they form a unique fingerprint.

Citation